Clinical Trials for MingSight Pharmaceuticals

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: MingSight Pharmaceuticals

Clinical Trials (1)

NCT06979076
A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL
PHASE1/PHASE2Not yet recruiting
12 participants
Started: Jul 31, 2026 · Completed: Dec 31, 2028
2 conditions1 sponsor0 locations